文献速递重症综合管理与镇静镇痛

脑死亡供者持续体外膜氧合期间的器官捐献与移植结局

Brain-Dead Donors on Extracorporeal Membrane Oxygenation.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论法国国家登记数据显示,持续体外膜氧合的脑死亡供者虽病情更重,但其肾移植1年存活率与功能、肝移植受者1年存活率与常规供者无显著差异,作者认为这类患者适合器官获取。

该研究为法国生物医学署CRISTAL国家登记数据库的回顾性分析,纳入2007至2013年法国所有脑死亡患者及其器官受者。研究期间共诊断22,270例脑死亡患者,其中161例接受体外膜氧合;64例持续体外膜氧合的供者与10,805例无体外膜氧合的供者至少获取一个器官。体外膜氧合供者显著更年轻,但血流动力学、生化、肾脏和肝脏等重症监护病情更严重。从体外膜氧合供者成功移植109个肾脏、37个肝脏、7个心脏和1个肺;肾移植1年移植物存活率(92.7% [85.9-96.3%] vs 95.4% [93.0-97.0%],p=0.24)及功能、肝移植受者1年存活率(86.5% [70.5-94.1] vs 80.7% [79.8-81.6],p=0.91)与匹配的常规供者受者均无显著差异。作者结论认为持续体外膜氧合的脑死亡患者适合器官获取。

要点

  • 持续体外膜氧合的脑死亡供者与无体外膜氧合供者相比,肾移植1年移植物存活率无显著差异(92.7% [85.9-96.3%] vs 95.4% [93.0-97.0%],p=0.24)。
  • 持续体外膜氧合的脑死亡供者与无体外膜氧合供者相比,肝移植受者1年存活率无显著差异(86.5% [70.5-94.1] vs 80.7% [79.8-81.6],p=0.91)。
  • 持续体外膜氧合的脑死亡供者显著更年轻,且血流动力学、生化、肾脏和肝脏等重症监护病情更严重。
  • 从持续体外膜氧合的脑死亡供者成功移植109个肾脏、37个肝脏、7个心脏和1个肺。
  • 作者认为持续体外膜氧合的脑死亡患者适合器官获取。

适用人群与场景

  • 法国2007至2013年国家登记数据库中所有脑死亡供者及其器官受者。
  • 持续体外膜氧合的脑死亡供者64例,无体外膜氧合的脑死亡供者10,805例,均至少获取一个器官。

研究设计与关键结果

  • 研究类型:基于法国生物医学署CRISTAL国家登记数据库的回顾性分析,纳入2007至2013年法国所有脑死亡患者及其器官受者,无干预。
  • 研究期间共诊断22,270例脑死亡患者,其中161例接受体外膜氧合;64例持续体外膜氧合的供者和10,805例无体外膜氧合的供者至少获取一个器官。
  • 持续体外膜氧合的供者显著更年轻,且血流动力学、生化、肾脏和肝脏等重症监护病情更严重。
  • 从持续体外膜氧合的供者成功移植109个肾脏、37个肝脏、7个心脏和1个肺。
  • 肾移植1年移植物存活率:体外膜氧合供者受者为92.7% [85.9-96.3%],匹配的无体外膜氧合供者受者为95.4% [93.0-97.0%],无显著差异(p=0.24);两组肾功能亦无显著差异。
  • 肝移植受者1年存活率:体外膜氧合供者受者为86.5% [70.5-94.1],无体外膜氧合供者受者为80.7% [79.8-81.6],无显著差异(p=0.91)。

证据类型、等级与局限

  • 证据类型:基于国家登记数据库的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,持续体外膜氧合的脑死亡患者适合器官获取。
  • 持续体外膜氧合的脑死亡供者虽重症监护病情更严重,但肾移植1年移植物存活率及功能、肝移植受者1年存活率与常规供者无显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To describe donors after brain death with ongoing extracorporeal membrane oxygenation and to analyze the outcome of organs transplanted from these donors.

DESIGN: Retrospective analysis of the national information system run by the French Biomedicine Agency (CRISTAL database).

SETTING: National registry data of all donors after brain death in France and their organ recipients between 2007 and 2013.

PATIENTS: Donors after brain death and their organ recipients.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: During the study period, there were 22,270 brain-dead patients diagnosed in France, of whom 161 with extracorporeal membrane oxygenation. Among these patients, 64 donors on extracorporeal membrane oxygenation and 10,805 donors without extracorporeal membrane oxygenation had at least one organ retrieved. Donors on extracorporeal membrane oxygenation were significantly younger and had more severe intensive care medical conditions (hemodynamic, biological, renal, and liver insults) than donors without extracorporeal membrane oxygenation. One hundred nine kidneys, 37 livers, seven hearts, and one lung were successfully transplanted from donors on extracorporeal membrane oxygenation. We found no significant difference in 1-year kidney graft survival (p = 0.24) and function between recipients from donors on extracorporeal membrane oxygenation (92.7% [85.9-96.3%]) and matching recipients from donors without extracorporeal membrane oxygenation (95.4% [93.0-97.0%]). We also found no significant difference in 1-year liver recipient survival (p = 0.91): 86.5% (70.5-94.1) from donors on extracorporeal membrane oxygenation versus 80.7% (79.8-81.6) from donors without extracorporeal membrane oxygenation.

CONCLUSIONS: Brain-dead patients with ongoing extracorporeal membrane oxygenation have more severe medical conditions than those without extracorporeal membrane oxygenation. However, kidney graft survival and function were no different than usual. Brain-dead patients with ongoing extracorporeal membrane oxygenation are suitable for organ procurement.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bronchard R, Durand L, Legeai C, et al. Brain-Dead Donors on Extracorporeal Membrane Oxygenation. Crit Care Med. 2017. PMID: 28640022. doi:10.1097/CCM.0000000000002564

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。